Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Zdenek Benes, bamlanivimab anti-COVID drug

Zdenek Benes, director of the Thomayer University Hospital attends a press conference on received bamlanivimab anti-COVID drug supply, on February 26, 2021, in Prague, Czech Republic. (CTK Photo/Ondrej Deml)

E

bamlanivimab anti-COVID drug, pharmacist

A pharmacist shows bamlanivimab anti-COVID drug, which is available at the Thomayer University Hospital in Prague, Czech Republic, on February 26, 2021. (CTK Photo/Ondrej Deml)

E

bamlanivimab anti-COVID drug, pharmacist

A pharmacist shows bamlanivimab anti-COVID drug, which is available at the Thomayer University Hospital in Prague, Czech Republic, on February 26, 2021. (CTK Photo/Ondrej Deml)

E

bamlanivimab anti-COVID drug

A bamlanivimab anti-COVID drug supply is seen at the Thomayer University Hospital in Prague, Czech Republic, on February 26, 2021. (CTK Photo/Ondrej Deml)

E

Zdenek Benes, bamlanivimab anti-COVID drug

Zdenek Benes, director of the Thomayer University Hospital attends a press conference on received bamlanivimab anti-COVID drug supply, on February 26, 2021, in Prague, Czech Republic. (CTK Photo/Ondrej Deml)

E

Andrej Babis, Zdenek Benes

Czech Prime Minister Andrej Babis, left, and director of the Thomayer University Hospital Zdenek Benes, right, attend a press conference on received bamlanivimab anti-COVID drug supply, on February 26, 2021, in Prague, Czech Republic. (CTK Photo/Ondrej Deml)

E

bamlanivimab anti-COVID drug, patient

Bamlanivimab, a medicine preventing a severe course of COVID-19 was given to the first patient in Masaryk Memorial Cancer Institute (MMCI) in Brno, Czech Republic, Friday, March 5, 2021. (CTK Photo/Vaclav Salek)

E

bamlanivimab anti-COVID drug, patient

Bamlanivimab, a medicine preventing a severe course of COVID-19 was given to the first patient in Masaryk Memorial Cancer Institute (MMCI) in Brno, Czech Republic, Friday, March 5, 2021. (CTK Photo/Vaclav Salek)

E

bamlanivimab anti-COVID drug, patient

Bamlanivimab, a medicine preventing a severe course of COVID-19 was given to the first patient in Masaryk Memorial Cancer Institute (MMCI) in Brno, Czech Republic, Friday, March 5, 2021. (CTK Photo/Vaclav Salek)

E

bamlanivimab anti-COVID drug, patient

Bamlanivimab, a medicine preventing a severe course of COVID-19 was given to the first patient in Masaryk Memorial Cancer Institute (MMCI) in Brno, Czech Republic, Friday, March 5, 2021. (CTK Photo/Vaclav Salek)